Muscle Inflammation Susceptibility: A Potential Phenotype for Guiding Precision Rehabilitation After Total Hip Arthroplasty in End-Stage Osteoarthritis.
inflammation
muscle
osteoarthritis
rehabilitation
total hip arthroplasty
Journal
HSS journal : the musculoskeletal journal of Hospital for Special Surgery
ISSN: 1556-3316
Titre abrégé: HSS J
Pays: United States
ID NLM: 101273938
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
22
06
2023
accepted:
26
06
2023
medline:
8
11
2023
pubmed:
8
11
2023
entrez:
8
11
2023
Statut:
ppublish
Résumé
The progression of osteoarthritis of the hip to its end stage and ultimately to total hip arthroplasty (THA) is complex; the multifactorial pathophysiology involves myriad collaborating tissues in and around the diseased joint. We have named the heightened state of periarticular muscle inflammation at the time of surgery "muscle inflammation susceptibility" (MuIS) because it is distinct from systemic inflammation. In this review article, we discuss how MuIS and heightened atrophy-associated signaling in the periarticular skeletal muscles may contribute to reduced muscle mass, impaired muscle quality (ie, through fibrosis), and a muscle microenvironment that challenges regenerative capacity and thus functional recovery from THA. We also review directions for future research that should advance understanding of the key determinants of precision for optimized success of THA for each individual.
Identifiants
pubmed: 37937084
doi: 10.1177/15563316231190402
pii: 10.1177_15563316231190402
pmc: PMC10626939
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
453-458Informations de copyright
© The Author(s) 2023.
Déclaration de conflit d'intérêts
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Am J Phys Med Rehabil. 2023 Jan 1;102(1):11-18
pubmed: 35302955
J Appl Physiol (1985). 2022 Apr 1;132(4):984-994
pubmed: 35238652
BMC Musculoskelet Disord. 2014 Apr 11;15:127
pubmed: 24725511
Am J Physiol Cell Physiol. 2023 May 1;324(5):C1078-C1088
pubmed: 36971423
Nat Rev Drug Discov. 2008 May;7(5):411-25
pubmed: 18404150
J Am Geriatr Soc. 2010 Dec;58(12):2387-93
pubmed: 21143444
Arthritis Rheumatol. 2022 Jul;74(7):1172-1183
pubmed: 35233975
Am J Phys Med Rehabil. 2015 Jan;94(1):70-81
pubmed: 25122094
Osteoarthritis Cartilage. 2018 Oct;26(10):1359-1368
pubmed: 29800621
Am J Physiol Endocrinol Metab. 2015 Apr 15;308(8):E670-9
pubmed: 25670829
J Immunol. 2009 Feb 15;182(4):2439-48
pubmed: 19201899
Adv Exp Med Biol. 2018;1088:267-279
pubmed: 30390256
Curr Opin Clin Nutr Metab Care. 2012 May;15(3):233-9
pubmed: 22366923
Int J Mol Sci. 2021 Mar 23;22(6):
pubmed: 33806895
J Bone Joint Surg Am. 2015 Sep 2;97(17):1386-97
pubmed: 26333733
BMC Musculoskelet Disord. 2016 Oct 7;17(1):421
pubmed: 27717340
Am J Physiol Cell Physiol. 2015 Jun 1;308(11):C932-43
pubmed: 25810256
Ann Transl Med. 2019 Oct;7(Suppl 7):S255
pubmed: 31728379
J Immunol. 2007 Dec 1;179(11):7949-58
pubmed: 18025243
J Appl Physiol (1985). 2013 Sep;115(6):937-48
pubmed: 23681911
J Immunol. 2006 Aug 15;177(4):2610-20
pubmed: 16888023
Nat Genet. 2022 Dec;54(12):1816-1826
pubmed: 36411363
Physiol Genomics. 2022 Dec 1;54(12):501-513
pubmed: 36278270
Exp Gerontol. 2018 Jun;106:116-124
pubmed: 29481967
Tumour Biol. 2017 Jun;39(6):1010428317714624
pubmed: 28639899
J Immunol. 2002 Nov 15;169(10):6020-9
pubmed: 12421989
Physiol Genomics. 2010 Feb 4;40(3):141-9
pubmed: 19903761
Arthritis Rheum. 2012 Jun;64(6):1697-707
pubmed: 22392533
FEBS J. 2013 Sep;280(17):4131-48
pubmed: 23663276